LadRx Corporation (CYTR) Stock Analysis
DELISTED
What happened to LadRx Corporation (CYTR) stock?
LadRx Corporation (CYTR) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
LadRx Corporation (CYTR). LadRx Corporation (CYTR) is a biopharmaceutical company focused on developing cancer therapeutics. Their lead drug conjugate, aldoxorubicin, is in late-stage clinical trials, targeting a version of the anti-cancer drug doxorubicin.
Last analyzed: Mar 17, 2026Dated analysis: the newest financial statements on file are 25 months old (Sep 1, 2024), so the figures and score below describe that period, not today.
LadRx Corporation (CYTR) Healthcare & Pipeline Overview
CYTR OTC Market Information
CYTR trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy CYTR shares?
No. CYTR stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for CYTR elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before CYTR stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to LadRx Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.